Nantahala Capital Partners Limited Partnership - 16 Feb 2025 SCHEDULE 13G Report for Eagle Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (EGRX)

Filing Manager
Nantahala Capital Partners Limited Partnership
Reporting Manager
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP
Security
Eagle Pharmaceuticals, Inc. Common Stock, par value $0.001 per share
Symbol
EGRX
Shares outstanding
12,988,784 shares
Disclosed Ownership
810,630 shares
Ownership
6.2%
Form type
SCHEDULE 13G
Filing time
19 Feb 2025, 16:32:31 UTC
Date of event
16 Feb 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 6.2% 810,630 0 810,630 /s/ Taki Vasilakis Taki Vasilakis / Chief Compliance Officer Nantahala Capital Management, LLC
Wilmot B. Harkey 6.2% 810,630 0 810,630 /s/ Wilmot B. Harkey Wilmot B. Harkey / Manager
Daniel Mack 6.2% 810,630 0 810,630 /s/ Daniel Mack Daniel Mack / Manager